Bloomberg examines China plague cases, potential for disease spread

"Plague-spreading fleas are expanding their territory, putting more people at risk of catching the lethal illness, a WHO official said," Bloomberg reports, in an article that examines the recent deaths of three people in China from the pneumonic plague.

Bloomberg writes, "Centuries after bubonic plague, the most common form, killed millions in medieval Europe, the scourge remains entrenched in parts of Africa, Asia and the Americas."

A combination of widening areas for the virus to circulate via rats and their fleas as well as "increased human activity in central Asia and other affected areas is heightening the risk of human infection, said Eric Bertherat, a WHO doctor who has investigated outbreaks for eight years," the news service writes.  "We can expect more sporadic human cases in the future," according to Bertherat. "While plague is one of the most deadly infectious diseases, early diagnosis and treatment with generic antibiotics such as streptomycin and tetracycline cut patients’ mortality rate to less than 15 percent, according to the WHO," however, "[w]hen left unchecked, infection with pneumonic plague is almost always fatal, sometimes a day after symptoms begin," Bloomberg writes.

The article includes information about the development of vaccines to protect against plague pneumonia and the recent history of cases in China (Gale, 8/6).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.